Although the market development space of Chinese medicine formula particles is large, there are still some "hard wounds"

Pharmaceutical Network Market Analysis: Chinese medicine formula particles refers to the traditional Chinese medicine drink tablets in line with the norms of concocting as raw materials, made of modern pharmaceutical technology pure Chinese pharmaceutical type, with quick effect, good absorption, easy to take and carry the characteristics, in line with the modern fast-paced lifein recent years, the market demand for formula particles has been expandingdata show that in 2019 the domestic chinese medicine formula particle market size reached 20 billion yuan, the Chinese medicine formula particle market is expected to reach 40 billion in 2020 market sizebut the industry also pointed out that the Chinese medicine formula particle market development space is large, but there are still some "hard injuries."lack of uniform standards at present, the domestic Chinese medicine formula particles production enterprises are mostly based on their own conditions and past production experience, to explore the production process and quality standards, the use of the process and process parameters there are differencesin this case, there are certain differences in the quality of products of different manufacturersto this, there are pharmaceutical companies related to the person in charge said that the Chinese medicine formula particles pilot edified for nearly 20 years, but there has been no national standards, which is also the reason why China has not really liberalized the formula particle markettherefore, it is urgent to speed up the development of quality standards for Chinese medicine formula particlesNovember 8, 2019, the State Pharmacopeia Commission issued the "Publicity on the pilot unified standards for Chinese medicine formula particle varieties", a total of 160 Chinese medicine formula particle varieties have a unified standard to see the pilotin terms of national uniform standards, the State Drug Administration has organized the drafting of the "Technical Requirements for Quality Control and Standard-setting of Chinese Medicine Formula Particles(Draft for Comments) " for public comments, but so far the results have not been publishedtechnological innovation to enhance the Chinese medicine formula particles need to be extracted, separated, concentrated, drying, granulation, packaging and other production processes, each process is very importanttherefore, in order to ensure the quality and efficacy of products, related enterprises need to continue to increase technological innovation and equipment updatesto granulating equipment as an example, the current industry reflects that customers are more important is the increase in the productivity of graining, for this, graining equipment manufacturers need to improve the production capacity of granulation equipmentit is understood that there are drying machine manufacturers for this demand, developed a fully automatic dry legal granulation machine designed a two-channel granulation box, compared with the traditional single-channel granulation box, increased the area of the mesh inges, in the same granulation frequency frequency conditions, the area of contact with the screen and material increased, the sieve particles also increasedin addition, the increase disgranual chamber volume can significantly improve the ability to process the sieve particles, in improving the cutting, pressing, feeding three parts speed, but also effectively improve the overall production capacity of the dry legal granule machineat present, the domestic Chinese medicine formula particle market has been driven into the fast track of development, research institutions, equipment enterprises need to strengthen research and equipment upgrades in technological innovation, in order to help China's formula particle market more stable development support policies to be further improved, including from the fiscal, tax, industry, talent and other aspects to further improve the support policy, and further increase capital investment at present, only some provinces to the province's pilot Chinese medicine formula particle enterprises to give a certain preferential policy, through the extension to get the pilot, while liberalizing the expansion of production capacity, good head enterprises industry believes that, with the increasing concentration of the industry, other qualified small and medium-sized enterprises also need to support the further improvement of policies in general, China's formula particle market to improve the space is huge, with the future policy liberalization, health insurance will also be gradually promoted in the country, in this context, formula particle market will usher in the volume but at the same time see the opportunity, the industry's "hard injury" also needs to be resolved, in order to promote the steady development of the industry